HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesIdarubicin
Chemical structure of CAS 58957-92-9

Idarubicin

CAS No.58957-92-9
MDL No.N/A
MFC26H27NO9
MW497.50
InChI KeyXDXDZDZNSLXDNA-TZNDIEGXSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Idarubicin is a monosaccharide derivative, an anthracycline antibiotic, and a deoxy hexoside derived from a tetracene hydride.

CAS No.58957-92-9
Product NameIdarubicin
Heavy Atom Count36Rotatable Bond Count3
Atom Stereo Count6Bond Stereo Count0
HBA10HBD5
TPSA176.610 ŲCharge0
Exact Mass497.16858Complexity1292.81
pKa2.203XLogP1.020

Related Articles

Studies related to this compound and its mechanism of action

Severe hepatic injury associated with lipid formulations of amphotericin B.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • Vol. 32, Issue 5 • 2001
PMID: 11229863DOI: 10.1086/319201

PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR.

Transfusion • Vol. 41, Issue 1 • 2001
PMID: 11161255DOI: 10.1046/j.1537-2995.2001.41010111.x

Isodicentric 7p, idic(7)(q11.2), in acute myeloid leukemia associated with older age and favorable response to induction chemotherapy: a new clinical entity?

Genes, chromosomes & cancer • Vol. 30, Issue 3 • 2001
PMID: 11170283DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1087>3.0.co;2-a

Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action.

Current medicinal chemistry • Vol. 8, Issue 1 • 2001
PMID: 11172692DOI: 10.2174/0929867013373967

Documentation

Similar Products